Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Faure

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Nature Communications|February 26, 2016
A workflow to process 3D+time microscopy images of developing organisms and reconstruct their cell lineageEmmanuel Faure, Thierry Savy, Barbara Rizzi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2024
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective studyAurélie Jourdes, Elise Cellerin, Cyrille Touzeau, et al.
Scientific Data|March 25, 2026
2D Multimodal Image Collection for Fluorescence Prediction from Transmitted Light MicroscopyDorian Kauffmann, Guillaume Gay, Julio Mateos-Langerak, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2021
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohortNadège Néant, Guillaume Lingas, Quentin Le Hingrat, et al.
Nucleic Acids Research|November 18, 2017
ANISEED 2017: extending the integrated ascidian database to the exploration and evolutionary comparison of genome-scale datasetsMatija Brozovic, Christelle Dantec, Justine Dardaillon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.
Brain : a Journal of Neurology|June 18, 2026
Long-term prognosis of patients surviving progressive multifocal leukoencephalopathyNicolas Lambert, Majdouline El Moussaoui, Adèle Le Guilloux, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesAdrian Gervais, Astrid Marchal, Alexis Maillard, et al.
The Journal of Infection|February 17, 2024
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trialMaya Hites, Clément R Massonnaud, Eva Larranaga Lapique, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 22, 2025
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trialClément R Massonnaud, Nathan Peiffer-Smadja, Pascal Poignard, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Nature Communications|February 26, 2016
A workflow to process 3D+time microscopy images of developing organisms and reconstruct their cell lineageEmmanuel Faure, Thierry Savy, Barbara Rizzi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2024
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective studyAurélie Jourdes, Elise Cellerin, Cyrille Touzeau, et al.
Scientific Data|March 25, 2026
2D Multimodal Image Collection for Fluorescence Prediction from Transmitted Light MicroscopyDorian Kauffmann, Guillaume Gay, Julio Mateos-Langerak, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2021
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohortNadège Néant, Guillaume Lingas, Quentin Le Hingrat, et al.
Nucleic Acids Research|November 18, 2017
ANISEED 2017: extending the integrated ascidian database to the exploration and evolutionary comparison of genome-scale datasetsMatija Brozovic, Christelle Dantec, Justine Dardaillon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.
Brain : a Journal of Neurology|June 18, 2026
Long-term prognosis of patients surviving progressive multifocal leukoencephalopathyNicolas Lambert, Majdouline El Moussaoui, Adèle Le Guilloux, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesAdrian Gervais, Astrid Marchal, Alexis Maillard, et al.
The Journal of Infection|February 17, 2024
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trialMaya Hites, Clément R Massonnaud, Eva Larranaga Lapique, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 22, 2025
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trialClément R Massonnaud, Nathan Peiffer-Smadja, Pascal Poignard, et al.
Pageof 9